The existence of a universal definition of myocardial infarction—which involves classification
into multiple subtypes—has promoted the use of standard diagnostic criteria across the …

Serological assessment of cardiac troponins (cTn) is the gold standard to assess myocardial
injury in clinical practice. A greater magnitude of acutely or chronically elevated cTn …

Although guidelines recommend fixed cardiac troponin thresholds for the diagnosis of
myocardial infarction, troponin concentrations are influenced by age, sex, comorbidities and …

A substantial number of chronic coronary syndrome (CCS) patients undergoing
percutaneous coronary intervention (PCI) experience periprocedural myocardial injury or …

BACKGROUND: Immune checkpoint inhibitors (ICIs) are approved for multiple cancers but
can result in ICI-associated myocarditis, an infrequent but life-threatening condition …

Aims Cardiac troponin T and I can be measured using a number of high-sensitivity (hs)
assays. This study aimed to characterize correlations between four such assays and test …

Plasma circulating extracellular vesicles (EVs) have been utilized as a potential therapeutic
strategy to treat ischemic disease through intramyocardial injection (efficient but invasive) or …

The use of biomarkers is undisputed in the diagnosis of primary myocardial infarction (MI),
but their value for identifying MI is less well studied in the postoperative phase following …

The term “single-sample rule-out” refers to the ability of very low concentrations of high-
sensitivity cardiac troponin (hs-cTn) on presentation to exclude acute myocardial infarction …

Acute myocardial infarction (AMI) represents a leading cause of death globally. Key to AMI
recovery is timely diagnosis and initiation of treatment, ideally within 3 h of symptom onset …